Characterization of cancer stem-like cells derived from a single 4T1 murine triple-negative breast cancer cell: Involvement of Akt‒mTOR pathway in the proliferation and sphere formation
Archives of Biochemistry and Biophysics · 2027-01 · 787 · 111050
DOI: 10.1016/j.abb.2026.111050 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2027-01. Verfasst von Masato Maruyama und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Okayama University, Okayama, 700-8530, Japan. Electronic address: maruyamm@okayama-u…. Die Arbeit nennt 61 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Triple-negative breast cancer (TNBC) is refractory, which could be likely ascribed to cancer stem cells (CSCs) harbored in TNBC. Therefore, to develop a novel therapeutic strategy for TNBC by targeting CSCs, we established and characterized 4T1-derived CSC-like cells. First, cell clones were obtained from a single mouse TNBC 4T1 cell utilizing a sphere-formation method. Then, their CSC-like properties were investigated for several CSC markers and in-vivo tumorigenicity to select 4T1-derived CSC-like cell clones. Among 16 cell clones obtained, the 6A10 and 6A12 clones highly expressed a CSC marker, CD44 variant, and stem-cell marker genes, such as Oct3/4, Sox2, and Nanog. Furthermore, these clones exhibited significantly greater in-vivo tumorigenicity than the parental 4T1 cells did in the mice that received subcutaneous injections of the cell suspension. These results clearly indicated that the two clones should be 4T1-derived CSC-like cells. To identify potential therapeutic targets for TNBC stem cells, the effects of various signaling inhibitors on cell proliferation and sphere formation were subsequently evaluated in the two established CSC-like cell clones. Notably, the mTOR inhibitor, rapamycin, and Akt inhibitor, GSK2110183, significantly suppressed both cell proliferation and sphere formation. Western blot analysis suggested that Akt activation was involved in mTOR phosphorylation in 6A10 cells. In conclusion, 4T1-derived CSC-like cells were successfully established from a single mouse TNBC cell, and it was suggested that the Akt-mTOR pathway was involved in the proliferation and sphere formation. The current results provide a promising therapeutic target for eliminating TNBC stem cells.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Okayama University, Okayama, 700-8530, Japan. Electronic address: maruyamm@okayama-u.ac.jp.
- Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Okayama University, Okayama, 700-8530, Japan.
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Maruyama, M., Yoshitomi, T., Seguchi, M., Hiraoka, W., & Higaki, K. (2027). Characterization of cancer stem-like cells derived from a single 4T1 murine triple-negative breast cancer cell: Involvement of Akt‒mTOR pathway in the proliferation and sphere formation. Archives of Biochemistry and Biophysics, 787, 111050. https://doi.org/10.1016/j.abb.2026.111050
Vancouver
Maruyama M, Yoshitomi T, Seguchi M, Hiraoka W, Higaki K. Characterization of cancer stem-like cells derived from a single 4T1 murine triple-negative breast cancer cell: Involvement of Akt‒mTOR pathway in the proliferation and sphere formation. Archives of Biochemistry and Biophysics. 2027;787:111050. doi:10.1016/j.abb.2026.111050
BibTeX
@article{Maruyama2027,
author = {Maruyama, Masato and Yoshitomi, Taketo and Seguchi, Miho and Hiraoka, Wataru and Higaki, Kazutaka},
title = {Characterization of cancer stem-like cells derived from a single 4T1 murine triple-negative breast cancer cell: Involvement of Akt‒mTOR pathway in the proliferation and sphere formation},
journal = {Archives of Biochemistry and Biophysics},
year = {2027},
volume = {787},
pages = {111050},
doi = {10.1016/j.abb.2026.111050}
}
EUVIMED